![Shannon Morris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shannon Morris
Directeur Technique/Scientifique/R&D chez
ERASCA, INC.
Fortune : - $ au 31/05/2026
Profil
Shannon R.
Morris is President & Partner at Sigma Group, Inc. since 2011.
Dr. Morris is Chief Medical Officer at Erasca, Inc. since 2023.
Former roles include Senior Director at MedImmune LLC from 2014 to 2017, Vice President-Clinical Development at G1 Therapeutics, Inc. from 2017 to 2020, and Vice President & Head-Clinical Development at Istari Oncology, Inc. from 2020 to 2022.
Education includes undergraduate studies at Stanford University and a doctorate from Case Western Reserve University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ERASCA, INC. -.--% | 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Shannon Morris
| Sociétés | Poste | Début |
|---|---|---|
| ERASCA, INC. | Directeur Technique/Scientifique/R&D | 25/05/2022 |
Sigma Group, Inc.
 Sigma Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising services | President | - |
Anciens postes connus de Shannon Morris
| Sociétés | Poste | Fin |
|---|---|---|
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Directeur Technique/Scientifique/R&D | 01/03/2022 |
| G1 THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2020 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Directeur/Membre du Conseil | 01/03/2017 |
Formation de Shannon Morris
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigma Group, Inc.
Sigma Group, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising services | Commercial Services |
G1 Therapeutics, Inc.
 G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Focuses on novel immuno-oncology and immunotherapy platforms for treatment of glioblastoma and tumors | Health Technology |
Erasca, Inc.
 Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
